Keep This Stock on Your Watchlist
They're a private company, but the same firms that backed Uber, eBay, and Venmo already invested in Pacaso. They've even reserved their Nasdaq stock ticker.
Social Security whistleblower who claims DOGE mishandled Americans' sensitive data resigns from post
WASHINGTON (AP) — A Social Security official who has filed a whistleblower complaint alleging the Department of Government Efficiency officials Americans' sensitive information says he's resigning his post because of actions taken against him since making his complaint.
Takeaways from scientists on the Trump administration's work on climate change and public health
WASHINGTON (AP) — A Trump administration proposal to reverse a landmark finding that climate change is dangerous to the public relies heavily on a report from the Department of Energy that dozens of scientists say is flawed.
How to Hack a $1.3 Trillion Industry - Ad
Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Led by former Zillow execs, their tech hacks a $1.3T market by letting buyers co-own homes worldwide. They've already earned $110M in gross profits and reserved the Nasdaq ticker PCSO.
Cat in San Francisco euthanized after latest bird flu infection tied to raw pet food
Federal health officials are warning that certain lots of raw cat food may be contaminated after a pet cat in San Francisco that ate the food became infected with the virus and had to be euthanized.
Walmart recalls frozen shrimp over potential radioactive contamination
Walmart has recalled frozen, raw shrimp sold in 13 states because federal health officials say it could have potential radioactive contamination.
Keep This Stock on Your Watchlist - Ad
They're a private company, but the same firms that backed Uber, eBay, and Venmo already invested in Pacaso. They've even reserved their Nasdaq stock ticker.
LSD shows promise for reducing anxiety in drugmaker's midstage study
WASHINGTON (AP) — reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a that has been banned in the U.S. for more than a half century.
Trump administration agrees to restore health websites and data
NEW YORK (AP) — Federal officials have agreed to restore and science-related webpages and data under to a lawsuit settlement with doctors groups and other organizations who sued.
4 Analysts. 4 Buy Ratings: Huge Potential Revaluation Ahead For This Biotech - Ad
This biotech is targeting a billion-dollar heart market. Analyst upside targets are in triple digit percentage gains.
This Merck Pill Promises Powerful Cholesterol Reduction Without Injections
Merck's Coralreef Lipids trial showed enlicitide cut LDL-C and other lipid markers, while pooled Verquvo data hinted at heart failure benefits.
Bernie Sanders Demands Health Secretary RFK Jr.'s Resignation As CDC Leadership Crisis Deepens
Senator Bernie Sanders called for HHS Secretary RFK Jr.'s resignation over his anti-vaccine policies, ousting of CDC Director Susan Monarez.
Major Investors Bet Big on This "Unlisted" Stock - Ad
When the former Zillow exec whose first venture sold for $120M starts a new company, people notice. No wonder the VCs behind Uber and eBay also backed Pacaso. Their platform sells fractions of premier properties, rewriting a $1.3T market. And it works, earning over $110M in gross profit to date.
More companies pull thousands of packages of shrimp for potential radioactive contamination
More companies are recalling tens of thousands of packages of imported shrimp sold at Walmart, Kroger and other U.S. stores because they may contain according to federal notices.
Fire departments concerned about cancer risks are buying gear that is free of forever chemicals
EAST PROVIDENCE, R.I. (AP) — Every time he rushed out on a fire call, East Providence Lt. Thomas Votta knew he put himself at risk for cancer. There are potential carcinogens in the smoke billowing out of a house fire, but also risks from wearing his .
The $4.4 Trillion Shift Few See Coming - Ad
McKinsey says AI could add $4.4T annually. Microsoft, Salesforce, and early startups are racing ahead. But one small-cap with $3B processed and 88% margins is ready to launch its consumer agents.
UK Patients Scramble For Mounjaro As Eli Lilly's 170% Price Hike Plan Sparks Shortages, Health Fears
Patients in UK struggle to obtain Mounjaro drug due to high demand, sharp price increase. Shortages causing stress and health risks.
CDC dramatically scales back program that tracks food poisoning infections
Federal health officials have dramatically scaled back a program that has tracked food poisoning infections in the U.S. for three decades.
Keep This Stock on Your Watchlist - Ad
They're a private company, but the same firms that backed Uber, eBay, and Venmo already invested in Pacaso. They've even reserved their Nasdaq stock ticker.
4 key decisions for early retirement
I was chatting with a friend the other day about his retirement — possibly an early one. At age 60, he has worked hard and invested well — and he’s burned out.
Marker Therapeutics Stock Drops After Report About Lymphoma Treatment
Marker Therapeutics reports strong safety and efficacy data for MT-601 in lymphoma patients, with durable responses and no serious adverse events.
Tens of Millions in Interest Saved. Zero-Party Data Is Next. - Ad
Over $8mm in annual payments revenue. That's the floor. The ceiling? Zero-party data licensed through AI Agents in a $4.4T market. The shift from cookies to consumer-owned data is here.
Study says AI chatbots inconsistent in handling suicide-related queries
A study of how three popular artificial intelligence chatbots respond to queries about suicide found that they generally avoid answering questions that pose the highest risk to the user, such as for specific how-to guidance. But they are inconsistent in their replies to less extreme prompts that could still harm people.
MannKind, Backed By Blackstone, Expands Cardiorenal Focus With $360 Million Deal
MannKind will acquire scPharmaceuticals in a $360 million deal, adding Furoscix and expanding into cardiometabolic care with a $10 billion U.S. market opportunity.
From $3B Processed to the Next AI Boom - Ad
This small-cap isn't hype. It's scaled. $3B+ in transactions. 1M+ live payments. Locked-in licensing revenue of $500k per year. Now it's about to roll out consumer AI agents, the real catalyst.
North Carolina Supreme Court says bar owners' COVID-19 lawsuits can continue
RALEIGH, N.C. (AP) — The North Carolina Supreme Court issued favorable rulings Friday for bars and their operators in litigation seeking monetary compensation from the state for COVID-19 restrictions first issued by then-Gov. Roy Cooper that shuttered their doors and, in their view, treated them unfairly compared to the way restaurants were regulated.
More frozen shrimp recalled for possible radioactive contamination
More packages of frozen shrimp potentially affected by have been recalled, federal officials said Thursday.
Missed Chatbots? Don't Miss AI Agents - Ad
Investors who rode C3.ai and SoundHound saw billions created overnight. The next wave? AI Agents. Acting, transacting, rewarding users, not just talking. $3B processed, 88% margins, launch in Q3 2025.
Many towns are unprepared to handle train derailments and hazmat spills
A train derails and spills at least 1,000 gallons of hazardous materials in the U.S. about once every two months. Nearly half of those derailments resulted in evacuations; more than a quarter resulted in a fire or explosion since 2015, an analysis of federal derailment data showed.
Minnesota sues TikTok, alleging it preys on young people with addictive algorithms
ST. PAUL, Minn. (AP) — Minnesota on Tuesday joined a wave of , alleging the social media giant preys on young people with addictive algorithms that trap them into becoming compulsive consumers of its short videos.
$9 Target on a $1.50 Biotech. Time to Look Closer - Ad
This biotech is targeting a billion-dollar heart market. Analyst upside targets are in triple digit percentage gains.
Berkshire's UnitedHealth Bet Highlights Long-Term Confidence Despite Depressed Earnings
Michael Burry and Warren Buffett invested in UnitedHealth, signaling confidence in its sector and potential for earnings recovery by 2027.
FDA's new expert panels are rife with financial conflicts and fringe views
WASHINGTON (AP) — When the needs outside guidance, it normally turns to a trusted source: a large roster of who are carefully vetted for their independence, credentials and judgment.
How to Hack a $1.3 Trillion Industry - Ad
Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Led by former Zillow execs, their tech hacks a $1.3T market by letting buyers co-own homes worldwide. They've already earned $110M in gross profits and reserved the Nasdaq ticker PCSO.
Some workers would be excluded from student loan forgiveness program for 'illegal' activity
WASHINGTON (AP) — Teachers, social workers, nurses and other public workers would be cut off from a popular if the Trump administration finds their employer engaged in activities with a “substantial illegal purpose,” under a new federal proposal released on Friday.
Novo Nordisk's Lead Fades, Eli Lilly Holds Course For Outsized Gains, Says Analyst
Eli Lilly's pricing strategy for GLP-1 drugs is expected to have minimal margin impact, with BofA reaffirming a $900 price target.
Keep This Stock on Your Watchlist - Ad
They're a private company, but the same firms that backed Uber, eBay, and Venmo already invested in Pacaso. They've even reserved their Nasdaq stock ticker.
Kellogg says it will remove artificial dyes from cereals by the end of 2027
NEW YORK (AP) — WK Kellogg Co. plans to remove artificial dyes in the next two and a half years, according to the company and the attorney general of Texas. The maker of Froot Loops and Apple Jacks gave the timeline as U.S. food producers face increasing pressure from the U.S. government and consumers to from their products.
White House Eyes Up to 250% Drug Tariffs In Bid To Reclaim US Pharma Supply Chain
White House trade adviser Peter Navarro discusses tariffs on pharma imports under a "Section 232" trade investigation.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.